These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16626655)

  • 41. Type-1 cannabinoid receptor activity during Alzheimer's disease progression.
    Manuel I; González de San Román E; Giralt MT; Ferrer I; Rodríguez-Puertas R
    J Alzheimers Dis; 2014; 42(3):761-6. PubMed ID: 24946872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats.
    Berrendero F; Romero J; García-Gil L; Suarez I; De la Cruz P; Ramos JA; Fernández-Ruiz JJ
    Biochim Biophys Acta; 1998 Sep; 1407(3):205-14. PubMed ID: 9748581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kappa- and delta-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice.
    Urigüen L; Berrendero F; Ledent C; Maldonado R; Manzanares J
    Eur J Neurosci; 2005 Oct; 22(8):2106-10. PubMed ID: 16262648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Miniature synaptic events elicited by presynaptic Ca2+ rise are selectively suppressed by cannabinoid receptor activation in cerebellar Purkinje cells.
    Yamasaki M; Hashimoto K; Kano M
    J Neurosci; 2006 Jan; 26(1):86-95. PubMed ID: 16399675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain.
    Breivogel CS; Childers SR; Deadwyler SA; Hampson RE; Vogt LJ; Sim-Selley LJ
    J Neurochem; 1999 Dec; 73(6):2447-59. PubMed ID: 10582605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.
    Ross RA; Brockie HC; Stevenson LA; Murphy VL; Templeton F; Makriyannis A; Pertwee RG
    Br J Pharmacol; 1999 Feb; 126(3):665-72. PubMed ID: 10188977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.
    Marusich JA; Wiley JL; Lefever TW; Patel PR; Thomas BF
    Neuropharmacology; 2018 May; 134(Pt A):73-81. PubMed ID: 29113898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain.
    Sim-Selley LJ; Selley DE; Vogt LJ; Childers SR; Martin TJ
    J Neurosci; 2000 Jun; 20(12):4555-62. PubMed ID: 10844025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice.
    Monory K; Tzavara ET; Lexime J; Ledent C; Parmentier M; Borsodi A; Hanoune J
    Biochem Biophys Res Commun; 2002 Mar; 292(1):231-5. PubMed ID: 11890697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain.
    Glass M; Dragunow M; Faull RL
    Neuroscience; 1997 Mar; 77(2):299-318. PubMed ID: 9472392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma.
    Gustafsson K; Christensson B; Sander B; Flygare J
    Mol Pharmacol; 2006 Nov; 70(5):1612-20. PubMed ID: 16936228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen.
    Corchero J; Romero J; Berrendero F; Fernandez-Ruiz J; Ramos JA; Fuentes JA; Manzanares J
    Brain Res Mol Brain Res; 1999 Apr; 67(1):148-57. PubMed ID: 10101241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers.
    Bingham B; Jones PG; Uveges AJ; Kotnis S; Lu P; Smith VA; Sun SC; Resnick L; Chlenov M; He Y; Strassle BW; Cummons TA; Piesla MJ; Harrison JE; Whiteside GT; Kennedy JD
    Br J Pharmacol; 2007 Aug; 151(7):1061-70. PubMed ID: 17549048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The G protein-coupled cannabinoid-1 (CB1) receptor of mammalian brain: inhibition by phthalate esters in vitro.
    Bisset KM; Dhopeshwarkar AS; Liao C; Nicholson RA
    Neurochem Int; 2011 Oct; 59(5):706-13. PubMed ID: 21763743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.
    Wiley JL; Martin BR
    Chem Phys Lipids; 2002 Dec; 121(1-2):57-63. PubMed ID: 12505690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system.
    McAllister SD; Griffin G; Satin LS; Abood ME
    J Pharmacol Exp Ther; 1999 Nov; 291(2):618-26. PubMed ID: 10525080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cannabinoid modulation of memory consolidation within the cerebellum.
    Steinmetz AB; Freeman JH
    Neurobiol Learn Mem; 2016 Dec; 136():228-235. PubMed ID: 27818269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain.
    Hosohata K; Quock RM; Hosohata Y; Burkey TH; Makriyannis A; Consroe P; Roeske WR; Yamamura HI
    Life Sci; 1997; 61(9):PL115-8. PubMed ID: 9284087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
    Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
    Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.